Home Compare MAERSK-B.CO vs MRNA
Stock Comparison · Comparison

A.P. Møller - Mærsk A/S vs Moderna: Which Stock Looks Stronger in 2026?

A.P. Møller - Mærsk A/S holds the cleaner structural position, with the lead spread across stability and growth. Moderna does not offset that deficit through any equally strong structural edge elsewhere. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (MAERSK-B.CO: STOXX 600, MRNA: S&P 500).

Updated 2026-08-16

This is not just a one-metric split: both stability and growth materially support the lead. The overall score gap is 42 points in favour of A.P. Møller - Mærsk A/S.

Trajectory Similarity
0.64
Moderately similar
Peer-set rank: #16
within A.P. Møller - Mærsk A/S's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The strongest overlap appears in capital structure and revenue stability.

Similarity drivers
capital structurerevenue stability
What reduces the match
margin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
MAERSK-B.CO
A.P. Møller - Mærsk A/S
58
Peer-Score
Signal qualitylow
Peer basis: STOXX 600
vs
MRNA
Moderna, Inc.
16
Peer-Score
Signal qualitylow
Peer basis: S&P 500

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: MAERSK-B.CO vs MRNA Profitability 44 15 Stability 66 3 Valuation 66 30 Growth 59 8 MAERSK-B.CO MRNA
Gap Ranking
#1 Stability +63
#2 Growth +51
#3 Valuation +36
#4 Profitability +29
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for MAERSK-B.CO and MRNA Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer MAERSK-B.COMRNA Relative valuation Structural strength

A.P. Møller - Mærsk A/S looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) and peer-relative valuation score where available.

Entry today — historical context

Where MAERSK-B.CO and MRNA each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY MAERSK-B.CO Elevated · above norm 0th 50th 100th 63 pct gap MRNA Neutral · below norm 0th 50th 100th 99th 36th
Today MRNA sits in the lower-middle of its own 5-year history (36th percentile), while MAERSK-B.CO sits higher in its own history (99th). Within each stock's own 5-year context, MRNA is at a historically more favourable entry position than MAERSK-B.CO. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Stability
A.P. Møller - Mærsk A/S ranks near the top of the group on stability; Moderna, Inc. sits in the weaker half.
Growth
On growth, A.P. Møller - Mærsk A/S is positioned higher in the group, while Moderna, Inc. is closer to the middle.
Stability — Dominant Gap
MAERSK-B.CO
66
MRNA
3
Gap+63in favour of MAERSK-B.CO

The clearest distance comes from a steadier profile over time.

What else supports the lead

Growth also supports the lead, so the result is broader than one isolated gap.

What this means for the comparison

The lead is built on both stability and growth, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the MAERSK-B.CO vs MRNA comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar stability-and-growth comparisons

Explore how MAERSK-B.CO and MRNA each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.